Modulation of type‐iv collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type‐iv collagenase
暂无分享,去创建一个
[1] R. Eddy,et al. Completion of the primary structure of the human type IV collagenase preproenzyme and assignment of the gene (CLG4) to the q21 region of chromosome 16. , 1990, Genomics.
[2] A. Eisen,et al. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. , 1989, The Journal of biological chemistry.
[3] G. Markus,et al. Directed migration of murine and human tumor cells to collagenases and other proteases. , 1989, Cancer research.
[4] D. Gomez,et al. Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype. , 1988, Biochemical and biophysical research communications.
[5] Y. Iwamoto,et al. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. , 1988, Cancer research.
[6] W. Stetler-Stevenson,et al. Monoclonal antibodies to type IV collagenase recognize a protein with limited sequence homology to interstitial collagenase and stromelysin , 1988, FEBS letters.
[7] J. Seltzer,et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. , 1988, The Journal of biological chemistry.
[8] M. De,et al. Relationship of in vitro cell motility and colonization potential in a mouse colon adenocarcinoma (MCA-38) cell line. , 1988 .
[9] T. Salo,et al. Proteolytic degradation of extracellular matrix in tumor invasion. , 1987, Biochimica et biophysica acta.
[10] L. Liotta,et al. Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. , 1987, Cancer research.
[11] J. Wood,et al. Modification of the interaction of human renin with different substrates by monoclonal antibodies. , 1987, Clinical and experimental hypertension. Part A, Theory and practice.
[12] L. Liotta,et al. Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes. , 1986, The Journal of biological chemistry.
[13] L. Liotta,et al. Biochemical interactions of tumor cells with the basement membrane. , 1986, Annual review of biochemistry.
[14] K. Nabeshima,et al. Enhanced migration of tumor cells in response to collagen degradation products and tumor cell collagenolytic activity. , 1986, Invasion & metastasis.
[15] E. Lillehoj,et al. Normal and abnormal aspects of proteinuria. Part I: Mechanisms, characteristics and analyses of urinary protein. Part II: Clinical considerations. , 1986, Experimental pathology.
[16] G. Martin,et al. Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[17] L. Liotta,et al. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. , 1985, Journal of the National Cancer Institute.
[18] L. Liotta,et al. NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice , 1985, Molecular and cellular biology.
[19] M. Moeremans,et al. Sensitive visualization of antigen-antibody reactions in dot and blot immune overlay assays with immunogold and immunogold/silver staining. , 1984, Journal of immunological methods.
[20] K. Tryggvason,et al. Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase. , 1984, The Journal of biological chemistry.
[21] L. Liotta,et al. Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells. , 1983, The Journal of biological chemistry.
[22] L. Liotta,et al. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. , 1982, Biochemistry.
[23] L. Liotta,et al. Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells – role in metastasis , 1982, International journal of cancer.
[24] K. Tryggvason,et al. Biosynthesis of type IV procollagens. , 1980, Biochemistry.
[25] L. Liotta,et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.
[26] V. Oi. Immunoglobulin producing hybrid cell lines , 1980 .
[27] J. Foidart,et al. Laminin--a glycoprotein from basement membranes. , 1979, The Journal of biological chemistry.
[28] C. Milstein,et al. Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.
[29] P. Gallop,et al. Preparation and properties of soluble collagens , 1963 .